DrugPatentWatch Database Preview» See Plans and Pricing
« Back to Dashboard
Magnesium sulfateis the generic ingredient in nine branded drugs marketed by Fresenius Kabi Usa, Hospira, Hq Spclt Pharma, Mylan Labs Ltd, Baxter Hlthcare Corp, Exela Pharma Scs Llc, Hospira Inc, Braintree Labs, Baxter Hlthcare, Gator Pharms, and Novel Labs Inc, and is included in nineteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.
There are one hundred and forty-six drug master file entries for magnesium sulfate. Ten suppliers are listed for this compound. There is one tentative approval for this compound.
Recent Clinical Trials for magnesium sulfate
Identify potential brand extensions & 505(b)(2) entrants
|Dow University of Health Sciences||Early Phase 1|
|Wright State University||Phase 4|
Generic filers with tentative approvals for MAGNESIUM SULFATE
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.